Guoxin Hou
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 3
-
- RNA modifications and cancer 7
- Cancer therapeutics and mechanisms 3
- Circular RNAs in diseases 2
- Co-authors
- Panpan Liu (3 shared papers)Shijun Wen (3 shared papers)Jing Yang (1 shared paper)Yumin Hu (3 shared papers)Jing Lan Yang (2 shared papers)Peng Huang (2 shared papers)Jianwei Liao (2 shared papers)Jingjing Deng (6 shared papers)
- Journals
- Cell Death and Disease (2 papers)Medical Oncology (1 paper)Heliyon (1 paper)Cell Death Discovery (1 paper)Gene (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Guoxin Hou
33 papers receiving 632 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 183
- Molecular Biology 347
- Oncology 124
- Immunology 64
- Pulmonary and Respiratory Medicine 83
Countries citing papers authored by Guoxin Hou
This map shows the geographic impact of Guoxin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxin Hou more than expected).
Fields of papers citing papers by Guoxin Hou
This network shows the impact of papers produced by Guoxin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxin Hou. The network helps show where Guoxin Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoxin Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 147 | |
| 2 | 2018 | 93 | |
| 3 | 2017 | 92 | |
| 4 | 2018 | 42 | |
| 5 | 2019 | 25 | |
| 6 | Polyphyllin I (PPI) increased the sensitivity of hepatocellular carcinoma HepG2 cells to chemotherapy. | 2015 | 25 |
| 7 | 1994 | 24 | |
| 8 | 2022 | 21 | |
| 9 | 2019 | 21 | |
| 10 | 2020 | 17 | |
| 11 | 2021 | 15 | |
| 12 | 2019 | 13 | |
| 13 | 2016 | 11 | |
| 14 | 2023 | 9 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2022 | 7 |
About Guoxin Hou
Guoxin Hou is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 636 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Lung Cancer Research Studies (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Mechanisms and Therapy (3 papers), Cancer therapeutics and mechanisms (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (183 citations), Molecular Biology (347 citations), Oncology (124 citations), Immunology (64 citations) and Pulmonary and Respiratory Medicine (83 citations). Guoxin Hou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Panpan Liu, Shijun Wen, Jing Yang, Yumin Hu, Jing Lan Yang, Peng Huang, Jianwei Liao, Jingjing Deng, Zhimin Lu and Yiming Jiang. Their work appears in journals such as Cell Death and Disease, Medical Oncology, Heliyon, Cell Death Discovery and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.